The presence of undifferentiated CD44+CD24−/low tumor cells is an unfavorable prognostic marker in patients with breast cancer, and the increased proportion of CD44+CD24−/low cells is an indicator of probable metastases in the lymph nodes [7]. This evidence concerns the gene CD44 and breast cancer.